[go: up one dir, main page]

Fenton, 1984 - Google Patents

Investigation of the humoral immune response in tumor bearing dogs: the role of antitumor antibodies in tumor progression and regression

Fenton, 1984

Document ID
9308389617977923310
Author
Fenton M
Publication year

External Links

Snippet

Abstract The Canine Transmissible Venereal Sarcoma (CTVS) allograft provokes specific protective immune responses in immunocompetent animals, although circulating blocking antitumor antibodies have been identified. In this study, we used a complement-mediated …
Continue reading at search.proquest.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells

Similar Documents

Publication Publication Date Title
Cote et al. Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease
Poppema et al. In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease
Atkinson et al. Gastrointestinal cancer-associated antigen in immunoperoxidase assay
Hofmann et al. Thymic medullary cells expressing B lymphocyte antigens
Basten et al. A subpopulation of T cells bearing Fc receptors
Greaves et al. Acute lymphoblastic leukaemia associated antigen. III Alterations in expression during treatment and in relapse
Neudoerfl et al. The peripheral NK cell repertoire after kidney transplantation is modulated by different immunosuppressive drugs
Lepault et al. An in vivo assay for thymus-homing bone marrow cells
Sorigue et al. Expression of CD43 in chronic lymphoproliferative leukemias
EP1031835A1 (en) Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases.
EP1151298A1 (en) Methods and assay kits for detecting mononuclear cell phenotype
Colley et al. Cellular differentiation in the thymus: II. Thymus-specific antigens in rat thymus and peripheral lymphoid cells
Bezdekova et al. Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia
Jegalian et al. NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T-lymphoblastic lymphoma from thymoma
Akazawa et al. Higher human lymphocyte antigen class I expression in early‐stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes
Wahren et al. Multiple antigens as marker substances in germinal tumors of the testis
Porta et al. Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells
Carrasco et al. CD66 expression in acute leukaemia
Horwitz et al. Surface markers and electron microscopy of human blood L cells: a comparison with T and B lymphocytes
Fenton Investigation of the humoral immune response in tumor bearing dogs: the role of antitumor antibodies in tumor progression and regression
Garnis et al. Surface markers of small lymphocytes appearing in the mouse Ehrlich ascites tumour, host spleen and blood
Sarkar et al. A rabbit antiserum to a thymus extract specific for mouse thymus-derived cells
Redmond III et al. Chronic lymphocytic leukemia with osteolytic bone lesions, hypercalcemia, and monoclonal protein
Hussain et al. Prostate cancer: flow cytometric methods for detection of bone marrow micrometastases
Suwanagool et al. Value of tissue carcinoembryonic antigen in patients with colorectal carcinoma